Items tagged with Treatment
MSF issue brief: Ready, set, slow down (post with simple image)
New and promising DR-TB drugs are grabbing headlines but not reaching patients.
Treating drug-sensitive TB in India: Implementation of daily therapy with fixed-dose combinations (post with simple image)
A briefing document outlines critical steps needed to implement a new policy from the Indian government to switch to standard daily TB treatment using fixed-dose combinations. This change, which is in line with global recommendations for proper treatment, is welcome but has yet to be put into action.
ECDC: Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA (post with simple image)
This Expert Opinion outlines some pre-conditions that are considered to be essential at the national level prior to the use of new drugs for the treatment of tuberculosis, as well as specific conditions needed in order to successfully implement new TB drugs/regimens.
The bedaquiline donation program started on April 1 (post with simple image)
A webinar, explaining the bedaquiline donation program, will be conducted on April 14, 2015 at 8:00 am EST and can be accessed here.
Nigeria spends nearly US$1.5 million for procurement of treatment for people with multidrug-resistant TB (post with simple image)
The Nigerian government sanctioned US$1.42 million to procure quality assured Second Line Drugs (SLDs) that will be used to provide treatment for 500 multidrug-resistant TB (MDR-TB) patients. The second line drugs ordered by the government will be delivered by Stop TB Partnership’s Global Drug Facility starting June 2015.
Team lands NIH funds to examine tuberculosis and metabolism (post with simple image)
A team from Colorado State University will play a crucial role in a new project funded by the National Institutes of Health to examine factors that make people susceptible to the bacterium that causes tuberculosis and to discover new treatment strategies.
How to access the bedaquiline donation program: step by step (post with simple image)
This is a note for implementers providing a general overview and reviewing the steps they need to take in order to access the drug.
MSF response to announcement of Otsuka’s donation programme for the TB drug delamanid (post with simple image)
MSF continues to express concern over the use of limited-scope donation programmes as a primary means of providing access to new TB drugs in countries affected by drug-resistant TB, as they are not a long-term solution to facilitating scale-up of treatment.
TB Alliance launches “Nix-TB” clinical trial to test new XDR-TB treatment (post with simple image)
First clinical trial to test a new all-oral regimen for extensively drug-resistant TB; Nix-TB is a critical step in the development of a universal treatment for all types of TB.
Page 58 of 67 · Total posts: 0←First 57 58 59 Last→